H.C. Wainwright analyst Joseph Pantginis lowered the firm’s price target on Fortress Biotech (FBIO) to $17 from $26 and keeps a Buy rating on the shares. The firm updated the company’s model.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FBIO: